170(top 1%)
PR articles
22.7K(top 1%)
PR citations
51(top 1%)
PR h-index
61(top 1%)
h-index
207
documents
30.9K
doc citations
5.2K
citing journals
100
times ranked

Publications

172 peer-reviewed articles • 25,104 peer-reviewed citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | Citations
#ArticleIFCitationsLinks
1Patterns of migraine medication use in Norway: A nationwide registry-based observational study
Cephalalgia, 2024, 44,
4.17Citations (PDF)
2Continuous positive airway pressure in cluster headache: A randomized, placebo-controlled, triple-blind, crossover study
Cephalalgia, 2023, 43,
4.13Citations (PDF)
3Global epidemiology of migraine and its implications for public health and health policy
Nature Reviews Neurology, 2023, 19, 109-117
28.6354Citations (PDF)
4Insufficient sleep may alter cortical excitability near the migraine attack: A blinded TMS crossover study
Cephalalgia, 2023, 43,
4.114Citations (PDF)
5The HARDSHIP databases: a forthcoming free good from the Global Campaign against Headache7.09Citations (PDF)
6Onabotulinum toxin A block of the sphenopalatine ganglion in patients with persistent idiopathic facial pain: a randomized, triple-blind, placebo-controlled, exploratory, cross-over study
Cephalalgia, 2023, 43,
4.16Citations (PDF)
7Pain thresholds and suprathreshold pain after sleep restriction in migraine – A blinded crossover study
Cephalalgia, 2022, 42, 466-480
4.113Citations (PDF)
8FollowTheSutures: Piloting a new way to administer onabotulinumtoxinA for chronic migraine
Cephalalgia, 2022, 42, 590-597
4.119Citations (PDF)
9The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates7.0746Citations (PDF)
10The Global Campaign turns 18: a brief review of its activities and achievements7.043Citations (PDF)
11Ottar Sjaastad0.10Citations (PDF)
12Burden of Neurological Disorders Across the US From 1990-2017
JAMA Neurology, 2021, 78, 165
17.6578Citations (PDF)
13Harald Schrader0.10Citations (PDF)
14OnabotulinumtoxinA injection towards the SPG for treating symptoms of refractory chronic rhinosinusitis with nasal polyposis: a pilot study
Acta Oto-Laryngologica, 2021, 141, 934-940
0.93Citations (PDF)
15Clinical and vascular responses to propranolol and candesartan in migraine patients: A randomized controlled clinical trial0.91Citations (PDF)
16High sensitivity C-reactive protein and risk of migraine in a 11-year follow-up with data from the Nord-Trøndelag health surveys 2006–2008 and 2017–20197.022Citations (PDF)
17Time trends of major headache diagnoses and predictive factors. Data from three Nord-Trøndelag health surveys7.040Citations (PDF)
18Gir ACE-hemmere og angiotensinreseptorantagonister økt risiko for alvorlig covid-19?0.10Citations (PDF)
19Volume and shape of subcortical grey matter structures related to headache: A cross-sectional population-based imaging study in the Nord-Trøndelag Health Study
Cephalalgia, 2019, 39, 173-184
4.119Citations (PDF)
20Diffusion tensor imaging in middle-aged headache sufferers in the general population: a cross-sectional population-based imaging study in the Nord-Trøndelag health study (HUNT-MRI)7.018Citations (PDF)
21The impact of C-reactive protein levels on headache frequency in the HUNT study 2006–2008
BMC Neurology, 2019, 19,
1.921Citations (PDF)
22The burden of headache disorders in the Eastern Mediterranean Region, 1990-2016: findings from the Global Burden of Disease study 20167.030Citations (PDF)
23Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Lancet Neurology, The, 2019, 18, 459-480
17.94,388Citations (PDF)
24The crossover design for migraine preventives: an analyses of four randomized placebo-controlled trials7.05Citations (PDF)
25Cerebral cortical dimensions in headache sufferers aged 50 to 66 years: a population-based imaging study in the Nord-Trøndelag Health Study (HUNT-MRI)
Pain, 2019, 160, 1634-1643
4.216Citations (PDF)
26Remission of chronic headache: An 11-year follow-up study. Data from the Nord-Trøndelag Health Surveys 1995–1997 and 2006–2008
Cephalalgia, 2018, 38, 2026-2034
4.16Citations (PDF)
27White matter hyperintensities and headache: A population-based imaging study (HUNT MRI)
Cephalalgia, 2018, 38, 1927-1939
4.142Citations (PDF)
28Inverse relationship between type 1 diabetes mellitus and migraine. Data from the Nord-Trøndelag Health Surveys 1995–1997 and 2006–2008
Cephalalgia, 2018, 38, 417-426
4.132Citations (PDF)
29Visual and auditory cortical evoked potentials in interictal episodic migraine: The predictive value of a proposed diagnostic test should always be corrected for prevalence
Cephalalgia, 2018, 38, 1000-1001
4.10Citations (PDF)
30Do incident musculoskeletal complaints influence mortality? The Nord-Trøndelag Health study
PLoS ONE, 2018, 13, e0203925
2.33Citations (PDF)
31Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Lancet Neurology, The, 2018, 17, 954-976
17.91,665Citations (PDF)
32Headache following head injury: a population-based longitudinal cohort study (HUNT)7.035Citations (PDF)
33Pilot study of sphenopalatine injection of onabotulinumtoxinA for the treatment of intractable chronic migraine
Cephalalgia, 2017, 37, 356-364
4.135Citations (PDF)
34Paranasal sinus opacification in headache sufferers: A population-based imaging study (the HUNT study-MRI)
Cephalalgia, 2017, 37, 509-516
4.18Citations (PDF)
35Prevalence and burden of headache disorders in Lithuania and their public-health and policy implications: a population-based study within the Eurolight Project7.053Citations (PDF)
36Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
Lancet Neurology, The, 2017, 16, 877-897
17.92,068Citations (PDF)
37Does pain sensitivity change by migraine phase? A blinded longitudinal study
Cephalalgia, 2017, 37, 1337-1349
4.151Citations (PDF)
38Depicting the pterygopalatine ganglion on 3 Tesla magnetic resonance images1.18Citations (PDF)
39Incidental Intracranial Findings and Their Clinical Impact; The HUNT MRI Study in a General Population of 1006 Participants between 50-66 Years
PLoS ONE, 2016, 11, e0151080
2.3106Citations (PDF)
40Chronic musculoskeletal complaints as a predictor of mortality—The HUNT study
Pain, 2016, 157, 1443-1447
4.222Citations (PDF)
41Migraine and endothelial function: The HUNT3 Study
Cephalalgia, 2016, 36, 1341-1349
4.116Citations (PDF)
42Headaches in patients with previous head injuries: A population-based historical cohort study (HUNT)
Cephalalgia, 2016, 36, 1009-1019
4.118Citations (PDF)
43Headache yesterday in Karnataka state, India: prevalence, impact and cost7.027Citations (PDF)
44Headache, depression and anxiety: associations in the Eurolight project7.0203Citations (PDF)
45Interictal burden attributable to episodic headache: findings from the Eurolight project7.0131Citations (PDF)
46Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013
JAMA Pediatrics, 2016, 170, 267
8.5571Citations (PDF)
47Migraine as a predictor of mortality: The HUNT study
Cephalalgia, 2016, 36, 351-357
4.115Citations (PDF)
48Pilot study of sphenopalatine injection of onabotulinumtoxinA for the treatment of intractable chronic cluster headache
Cephalalgia, 2016, 36, 503-509
4.177Citations (PDF)
49Perivascular spaces and headache: A population-based imaging study (HUNT-MRI)
Cephalalgia, 2016, 36, 232-239
4.125Citations (PDF)
50Intracranial abnormalities and headache: A population-based imaging study (HUNT MRI)
Cephalalgia, 2016, 36, 113-121
4.123Citations (PDF)
51Headache and peak oxygen uptake: The HUNT3 study
Cephalalgia, 2016, 36, 437-444
4.129Citations (PDF)
52Headache as a predictor for dementia: The HUNT Study7.035Citations (PDF)
53Headache disorders and public ill-health in India: prevalence estimates in Karnataka State7.095Citations (PDF)
54The burden attributable to headache disorders in India: estimates from a community-based study in Karnataka State7.053Citations (PDF)
55Pharmacological treatment of migraine during pregnancy and breastfeeding
Nature Reviews Neurology, 2015, 11, 209-219
28.687Citations (PDF)
56Acetyl-l-carnitine versus placebo for migraine prophylaxis: A randomized, triple-blind, crossover study
Cephalalgia, 2015, 35, 987-995
4.123Citations (PDF)
57Paranasal sinus opacification at MRI in lower airway disease (the HUNT study-MRI)1.69Citations (PDF)
58Incidental findings in MRI of the paranasal sinuses in adults: a population-based study (HUNT MRI)2.447Citations (PDF)
59Diagnosis, prevalence estimation and burden measurement in population surveys of headache: presenting the HARDSHIP questionnaire7.0186Citations (PDF)
60A comparative study of candesartan versus propranolol for migraine prophylaxis: A randomised, triple-blind, placebo-controlled, double cross-over study
Cephalalgia, 2014, 34, 523-532
4.1160Citations (PDF)
61The methodology of population surveys of headache prevalence, burden and cost: Principles and recommendations from the Global Campaign against Headache7.0184Citations (PDF)
62Headache as a risk factor for dementia: A prospective population-based study
Cephalalgia, 2014, 34, 327-335
4.159Citations (PDF)
63Role of Angiotensin Modulation in Primary Headaches2.87Citations (PDF)
64The impact of headache in Europe: principal results of the Eurolight project7.0338Citations (PDF)
65Headache yesterday in Europe7.018Citations (PDF)
66Neurological disorders in the Global Burden of Disease 2010 study2.958Citations (PDF)
67Are Holen utnevnt til ridder av 1. klasse0.10Citations (PDF)
68Re: Ensidig om nakkesleng fra Høyesterett0.10Citations (PDF)
69Candesartan kan forebygge migrene0.10Citations (PDF)
70Re: Ensidig om nakkesleng fra Høyesterett0.10Citations (PDF)
71Re: Ensidig om nakkesleng fra Høyesterett0.10Citations (PDF)
72Re: Ensidig om nakkesleng fra Høyesterett0.10Citations (PDF)
73Sleep quality, arousal and pain thresholds in migraineurs: a blinded controlled polysomnographic study7.069Citations (PDF)
74Improving quality in population surveys of headache prevalence, burden and cost: key methodological considerations7.029Citations (PDF)
75Randomised trial on episodic cluster headache with an angiotensin II receptor blocker
Cephalalgia, 2013, 33, 1026-1034
4.116Citations (PDF)
76Unruptured Intracranial Aneurysms in the Norwegian Nord-Trøndelag Health Study (HUNT)
Neurosurgery, 2013, 73, 256-261
2.049Citations (PDF)
77Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010
Lancet, The, 2012, 380, 2129-2143
62.11,163Citations (PDF)
78A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
Lancet, The, 2012, 380, 2224-2260
62.110,173Citations (PDF)
79The burden of headache disorders in India: methodology and questionnaire validation for a community-based survey in Karnataka State
Journal of Headache and Pain, 2012, 13, 543-550
7.079Citations (PDF)
80Does health differ between participants and non-participants in the MRI-HUNT study, a population based neuroimaging study? The Nord-Trøndelag health studies 1984–20092.737Citations (PDF)
81Migraine Among Norwegian Neurologists
Headache, 2012, 52, 1369-1376
3.022Citations (PDF)
82Risk factors for medication-overuse headache: An 11-year follow-up study. The Nord-Trøndelag Health Studies
Pain, 2012, 153, 56-61
4.2168Citations (PDF)
83Will (or can) people pay for headache care in a poor country?7.027Citations (PDF)
84Medikamentell profylakse ved migrene0.10Citations (PDF)
85Høyesterett og sakkyndighet0.10Citations (PDF)
86Høyesterettsdommen er korrekt0.13Citations (PDF)
87The Nord-Trøndelag Health Study shows increased prevalence of primary recurrent headaches among adolescents over a four-year period1.510Citations (PDF)
88Cost of disorders of the brain in Europe 20101.01,441Citations (PDF)
89Increasing Prevalence of Chronic Musculoskeletal Complaints. A Large 11-Year Follow-Up in the General Population (HUNT 2 and 3)
Pain Medicine, 2011, 12, 1657-1666
2.095Citations (PDF)
90A 4-year follow-up of patients with medication-overuse headache previously included in a randomized multicentre study
Journal of Headache and Pain, 2011, 12, 315-322
7.044Citations (PDF)
91Association between blood pressure measures and recurrent headache in adolescents: cross-sectional data from the HUNT-Youth study
Journal of Headache and Pain, 2011, 12, 347-353
7.022Citations (PDF)
92Headache and migraine during pregnancy and puerperium: the MIGRA-study
Journal of Headache and Pain, 2011, 12, 443-451
7.0127Citations (PDF)
93The Eurolight project: the impact of primary headache disorders in Europe. Description of methods
Journal of Headache and Pain, 2011, 12, 541-549
7.055Citations (PDF)
94Endometriosis and Headache2.810Citations (PDF)
95Onabotulinum toxin A treatment of cervicogenic headache: A randomised, double-blind, placebo-controlled crossover study
Cephalalgia, 2011, 31, 797-807
4.136Citations (PDF)
96Response to ‘Comment on mobile phone headache: A double-blind, sham-controlled provocation study’
Cephalalgia, 2011, 31, 508-509
4.10Citations (PDF)
97Time trends in the prevalence of headache disorders. The Nord-Trøndelag Health Studies (HUNT 2 and HUNT 3)
Cephalalgia, 2011, 31, 585-596
4.185Citations (PDF)
98Fragliche nosologische Validität des chronischen Halswirbelschleudertraumasyndroms
Der Orthopade, 2011, 41, 147-152
0.59Citations (PDF)
99Mer meningsløst om nakkesleng0.11Citations (PDF)
100The validity of questionnaire-based diagnoses: the third Nord-Trøndelag Health Study 2006–20087.086Citations (PDF)
101Associations between sleep disturbance and primary headaches: the third Nord-Trøndelag Health Study
Journal of Headache and Pain, 2010, 11, 197-206
7.0134Citations (PDF)
102Prevalence of headache in Europe: a review for the Eurolight project
Journal of Headache and Pain, 2010, 11, 289-299
7.0471Citations (PDF)
103Medication overuse headache: a critical review of end points in recent follow-up studies
Journal of Headache and Pain, 2010, 11, 373-377
7.064Citations (PDF)
104Cost of disorders of the brain in Norway2.974Citations (PDF)
105Repeatability of cold pain and heat pain thresholds: The application of sensory testing in migraine research
Cephalalgia, 2010, 30, 904-909
4.113Citations (PDF)
106Development and validation of the EUROLIGHT questionnaire to evaluate the burden of primary headache disorders in Europe
Cephalalgia, 2010, 30, 1082-1100
4.141Citations (PDF)
107Feilaktig om bløtdelsskader etter nakkesleng0.12Citations (PDF)
108Meningsløst om nakkesleng0.11Citations (PDF)
109Vrengebilde av nakkeslengproblematikken0.10Citations (PDF)
110High dietary caffeine consumption is associated with a modest increase in headache prevalence: results from the Head-HUNT Study
Journal of Headache and Pain, 2009, 10, 153-159
7.045Citations (PDF)
111Interictal quantitative EEG in migraine: a blinded controlled study
Journal of Headache and Pain, 2009, 10, 331-339
7.0102Citations (PDF)
112New drugs for migraine
Journal of Headache and Pain, 2009, 10, 395-406
7.030Citations (PDF)
113Magnetic resonance imaging after most common form of concussion2.733Citations (PDF)
114Hypertension-associated hypalgesia: a clue to the comorbidity of headache and other pain disorders2.913Citations (PDF)
115Headache after concussion3.588Citations (PDF)
116Cerebrospinal Fluid Cytokine Levels in Migraine, Tension-Type Headache and Cervicogenic Headache
Cephalalgia, 2009, 29, 365-372
4.1106Citations (PDF)
117Similarities in stress physiology among patients with chronic pain and headache disorders: evidence for a common pathophysiological mechanism?7.034Citations (PDF)
118Impact of headache in Europe: a review for the Eurolight project7.0130Citations (PDF)
119A face-to-face interview of participants in HUNT 3: the impact of the screening question on headache prevalence7.027Citations (PDF)
120Whiplash Headache is Transitory Worsening of a Pre-Existing Primary Headache
Cephalalgia, 2008, 28, 28-31
4.116Citations (PDF)
121Epidemiology and comorbidity of headache
Lancet Neurology, The, 2008, 7, 354-361
17.9583Citations (PDF)
122Brainstem auditory-evoked potential habituation and intensity-dependence related to serotonin metabolism in migraine: A longitudinal study
Clinical Neurophysiology, 2008, 119, 1190-1200
1.363Citations (PDF)
123Visual evoked potential latency, amplitude and habituation in migraine: A longitudinal study
Clinical Neurophysiology, 2008, 119, 1020-1027
1.3114Citations (PDF)
124High pulse pressure protects against headache
Neurology, 2008, 70, 1329-1336
1.062Citations (PDF)
125High Systolic Blood Pressure Is Associated With Val/Val Genotype in the Catechol-O-Methyltransferase GeneThe Nord-Trøndelag Health Study (HUNT)2.045Citations (PDF)
126Autonomic activation and pain in response to low-grade mental stress in fibromyalgia and shoulder/neck pain patients
European Journal of Pain, 2007, 11, 743-755
3.069Citations (PDF)
127The impact of the Catechol-O-methyltransferase Val158Met polymorphism on survival in the general population – the HUNT study1.819Citations (PDF)
128Potentials and Pitfalls in Analytical Headache Epidemiological Studies—Lessons to be Learned from the Head-HUNT Study
Cephalalgia, 2007, 27, 403-413
4.136Citations (PDF)
129Mobile Phone Headache: A Double Blind, Sham-Controlled Provocation Study
Cephalalgia, 2007, 27, 447-455
4.191Citations (PDF)
130Cardiovascular responses to cognitive stress in patients with migraine and tension-type headache
BMC Neurology, 2007, 7,
1.913Citations (PDF)
131Migraine aura or transient ischemic attacks? A five-year follow-up case-control study of women with transient central nervous system disorders in pregnancy
BMC Medicine, 2007, 5,
7.122Citations (PDF)
132Noradrenaline and cortisol changes in response to low-grade cognitive stress differ in migraine and tension-type headache7.035Citations (PDF)
133Headaches add to the burden of epilepsy7.061Citations (PDF)
134Validation of a Georgian language headache questionnaire in a population-based sample7.021Citations (PDF)
135Oral contraceptives and increased headache prevalence: The Head-HUNT Study
Neurology, 2006, 66, 349-353
1.0101Citations (PDF)
136Prevalence, burden, and cost of headache disorders
Current Opinion in Neurology, 2006, 19, 281-285
3.885Citations (PDF)
137Epidemiology of headache in Europe3.5360Citations (PDF)
138Sick Leave is Related to Frequencies of Migraine and Non-Migrainous Headache—The HUNT Study
Cephalalgia, 2006, 26, 960-967
4.134Citations (PDF)
139Headache epidemiology: how and why?7.020Citations (PDF)
140The association between headache and Val158Met polymorphism in the catechol–O–methyltransferase gene: the HUNT Study7.054Citations (PDF)
141No association between chronic musculoskeletal complaints and Val158Met polymorphism in the Catechol-O-methyltransferase gene. The HUNT study2.151Citations (PDF)
142Does Hypertension Protect Against Chronic Musculoskeletal Complaints?8.184Citations (PDF)
143Do high TSH values protect against chronic musculoskeletal complaints? The Nord-Trøndelag Health Study (HUNT)
Pain, 2005, 113, 416-421
4.210Citations (PDF)
144A Randomized, Double Blind Study of the Prophylactic Effect of Hyperbaric Oxygen Therapy on Migraine
Cephalalgia, 2004, 24, 639-644
4.129Citations (PDF)
145Headache Prevalence Related to Haemoglobin and Ferritin. The HUNT Study
Cephalalgia, 2004, 24, 758-762
4.143Citations (PDF)
146Reply
Annals of Neurology, 2003, 53, 145-146
6.60Citations (PDF)
147Low Socio-Economic Status is Associated with Increased Risk of Frequent Headache: A Prospective Study of 22718 Adults in Norway
Cephalalgia, 2002, 22, 672-679
4.1132Citations (PDF)
148Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study0.1255Citations (PDF)
149Head-HUNT: Validity and Reliability of a Headache Questionnaire in a Large Population-Based Study in Norway
Cephalalgia, 2000, 20, 244-251
4.1133Citations (PDF)
150Prevalence of Migraine and Non-Migrainous Headache—Head-HUNT, A Large Population-Based Study
Cephalalgia, 2000, 20, 900-906
4.1229Citations (PDF)
151Sensitivity to Various Stimuli in Primary Headaches: A Questionnaire Study
Headache, 1999, 39, 552-558
3.047Citations (PDF)
152The Nosologic Status of the Whiplash Syndrome: A Critical Review Based on a Methodological Approach
Spine, 1996, 21, 2735-2746
2.4105Citations (PDF)
153CPH and Hemicrania Continua: Requirements of High Indomethacin Dosages -An Ominous Sign?
Headache, 1995, 35, 363-367
3.083Citations (PDF)
154Posterior cranial fossa dimensions in the Chiari I malformation: Relation to pathogenesis and clinical presentation
Neuroradiology, 1993, 35, 113-118
2.1246Citations (PDF)
155Side Alternation of Pain in Hemicrania Continua
Headache, 1993, 33, 43-44
3.021Citations (PDF)
156Headache Associated With the Chiari Type I Malformation.
Headache, 1993, 33, 175-181
3.090Citations (PDF)
157Cluster Headache In Identical Twins
Headache, 1993, 33, 214-217
3.085Citations (PDF)
158The IHS Classification For Common Migraine. Is It Ideal?
Headache, 1993, 33, 372-375
3.013Citations (PDF)
159Syringomyelia in Chiari Malformation
Neurosurgery, 1992, 31, 913-917
2.070Citations (PDF)
160Cluster Headache: Phospholipid Metabolism in Polymorphonuclear Cells
Cephalalgia, 1992, 12, 107-110
4.14Citations (PDF)
161Headache and Chiari type I Malformation: Occurrence in Female Monozygotic Twins and First-Degree Relatives
Cephalalgia, 1992, 12, 304-307
4.121Citations (PDF)
162The chiari type I malformation in two monozygotic twins and first‐degree relatives
Annals of Neurology, 1992, 31, 220-222
6.656Citations (PDF)
163Syringomyelia in Chiari Malformation
Neurosurgery, 1992, 31, 913???917
2.09Citations (PDF)
164Dental caries and periodontitis in persons with Down syndrome
Special Care in Dentistry, 1991, 11, 71-73
1.047Citations (PDF)
165"Hemicrania Continua": A Clinical Review
Headache, 1991, 31, 20-26
3.0175Citations (PDF)
166Short-lasting Unilateral Neuralgiform Headache Attacks with Conjunctival Injection, Tearing, etc. (SUNCT): III. Another Norwegian Case
Headache, 1991, 31, 175-177
3.043Citations (PDF)
167Cluster Headache: Incorporation of (1-14C)oleic Acid into Phosphatidylserine in Polymorphonuclear Cells
Cephalalgia, 1989, 9, 207-211
4.12Citations (PDF)
168Cluster Headache: Increased Incorporation of (1-14C)Arachidonic Acid into Phosphatidylserine in Polymorphonuclear Cells
Cephalalgia, 1989, 9, 213-220
4.14Citations (PDF)
169Increased Incorporation of L-(U-14C)serine into Phosphatidylserine in Polymorphonuclear Cells from Cluster Headache Patients
Cephalalgia, 1989, 9, 221-225
4.13Citations (PDF)
170Arachidonic Acid Metabolism in Polymorphonuclear Cells in Headaches: A Methodologic Study
Cephalalgia, 1988, 8, 149-155
4.110Citations (PDF)
171Title is missing!
0
103Citations (PDF)
172The effects of angiotensin receptor blockers as prophylactic migraine treatment: A systematic review and meta-analysis
Cephalalgia, 0, 46,
4.11Citations (PDF)